NURS 327 FINAL exam with precise detailed
| | | | | | |
answers
Primary |- |correct |answer | |The |local |YMCA |hosts |a |fire |safety |fair |for |the |community. |Which |level |of |
prevention |is |being |demonstrated?
nerve |agents |- |correct |answer | |muscarinic |agents= |develop |anticholinergic |crisis
-sludgem |syndrome |(wet |like |slug
-Salivation |- |stimulation |of |salivary |glands
-Lacrimation |- |stimulation |of |lacrimal |glands |(tears)
- |Urination- |relaxation |of |internal |sphincter |muscles |of |urethra |and |contraction |of |detrusor |muscle |
- |Diaphoresis- |stimulation |of |sweat |glands
- |Gastrointestinal |upset- |smooth |muscle |tone |changes |causing |GI |problems |and |diarrhea
- |Emesis- |vomiting
- |Miosis- |muscle |spasm
treatment |nerve |agent |- |correct |answer | |atropine
bioterrorism |- |correct |answer | |-deliberate |release |of |viruses, |bacteria, |or |other |agent |used |to |cause |
illness |or |death |in |people, |animals |or |plants
secondary |prevention |bioterrorism |- |correct |answer | |-early |recognition, |activation |of |bioterrorism |
response |plan
- |immediate |implementation |of |infection |control |and |containment |measures |
-decontamination
-environmental |disinfection
-protective |equipment, |community |education/ |notification |
,-quarantines |
-screening- |assess |for |exposure, |assess |rate |of |infection, |vaccines |as |available
- |educating |population- |symptoms |identification, |symptom |management |(immunoglobulin, |antiviral, |
antitoxins, |antibiotics)
- |monitor |mortality |and |morbidity
tertiary |prevention |- |correct |answer | |-rehab |of |survivors
- |monitor |medication |regimes |and |referrals
- |evaluation |of |the |effectiveness |and |timeliness |of |bioterrorism |plan
-mental |health
smallpox |- |correct |answer | |variola |major
- |category |A |
-incubation |period |7-17 |days |(asymptomatic |and |not |contagious)
-first |s/s; |fever, |malaise, |aches |(2-4 |days), |sometimes |contagious |
-early |rash; |small |red |spots |on |tongue |and |mouth |
- |break |open |and |virus |spreads
-MOST |contagious |time
- |rash |spreads |to |body |on |extremities
-pustular |rash |through |scab |and |recovery
-contagious |until |scabs |have |fallen |off
-contact |FBI |is |considered |a |bioterrorist |attack
- |lesions |differ |from |chicken |pox
-small |pox |lesions |develop |at |same |rate |as |chicken |pox |,then |become |pus |filled, |then |start |to |scab
- |mainly |on |face |and |extremities
smallpox |facts |- |correct |answer | |-last |case |1949 |in |US |and |1977 |in |somalia
-routine |vaccination |stopped |after |last |case
- |vaccine |only |prevention
, - |can |work |within |3 |days |of |exposure
- |transmitted |direct |and |prolonged |face |to |face |contact
-contact |with |infected |body |fluids
- |contact |with |contaminated |objects
response |is |smallpox |outbreak |- |correct |answer | |-mass |vaccinations
-crowd |control, |record |keeping |and |prioritization
category |A |- |correct |answer | |-high |priority |agents |including |organisms |that |pose |a |risk |to |national |
security |because |they |are |easily |transmitted
-high |mortality |rates |and |have |potential |for |major |public |health |impact
-might |cause |public |panic |and |social |disruption
- |require |special |action |for |public |health |preparedness
- |Anthrax |• |Botulism |• |Plague |• |Smallpox |• |Tularemia |• |Viral |hemorrhagic |fevers |(filoviruses |[e.g., |
Ebola, |Marburg] |and |arenaviruses |[e.g., |Lassa, |Machupo])
category |B |- |correct |answer | |-second |highest |priority |agents |include |those |that |are |moderately |easy |
to |disseminate
-result |in |moderate |morbidity |rates |and |low |mortality |rates
-require |specific |enhancement |of |CDCs |diagnostic |capacity |and |enhanced |disease |surveillance |
-brucellosis, |clostridium |perfringens, |salmonella, |e. |coli, |shigella, |q |fever, |ricin*, |staph |b, |vibrio |
cholerae, |cryptosporidium
category |C |- |correct |answer | |third |highest |priority |agents |include |emerging |pathogens |that |could |be |
engineered |for |mass |dissemination |in |the |future |because |of |: |availability |and |ease |of |production |and |
dissemination |and |potential |for |high |morbidity |and |mortality |rates |and |major |health |impact |
- |nipah |virus, |hantavirus, |HIV, |SARS, |H1N1
strategic |national |stockpile |- |correct |answer | |The |United |States' |national |repository |of |antibiotics, |
vaccines, |chemical |antidotes, |antitoxins, |and |other |critical |medical |equipment |and |supplies
| | | | | | |
answers
Primary |- |correct |answer | |The |local |YMCA |hosts |a |fire |safety |fair |for |the |community. |Which |level |of |
prevention |is |being |demonstrated?
nerve |agents |- |correct |answer | |muscarinic |agents= |develop |anticholinergic |crisis
-sludgem |syndrome |(wet |like |slug
-Salivation |- |stimulation |of |salivary |glands
-Lacrimation |- |stimulation |of |lacrimal |glands |(tears)
- |Urination- |relaxation |of |internal |sphincter |muscles |of |urethra |and |contraction |of |detrusor |muscle |
- |Diaphoresis- |stimulation |of |sweat |glands
- |Gastrointestinal |upset- |smooth |muscle |tone |changes |causing |GI |problems |and |diarrhea
- |Emesis- |vomiting
- |Miosis- |muscle |spasm
treatment |nerve |agent |- |correct |answer | |atropine
bioterrorism |- |correct |answer | |-deliberate |release |of |viruses, |bacteria, |or |other |agent |used |to |cause |
illness |or |death |in |people, |animals |or |plants
secondary |prevention |bioterrorism |- |correct |answer | |-early |recognition, |activation |of |bioterrorism |
response |plan
- |immediate |implementation |of |infection |control |and |containment |measures |
-decontamination
-environmental |disinfection
-protective |equipment, |community |education/ |notification |
,-quarantines |
-screening- |assess |for |exposure, |assess |rate |of |infection, |vaccines |as |available
- |educating |population- |symptoms |identification, |symptom |management |(immunoglobulin, |antiviral, |
antitoxins, |antibiotics)
- |monitor |mortality |and |morbidity
tertiary |prevention |- |correct |answer | |-rehab |of |survivors
- |monitor |medication |regimes |and |referrals
- |evaluation |of |the |effectiveness |and |timeliness |of |bioterrorism |plan
-mental |health
smallpox |- |correct |answer | |variola |major
- |category |A |
-incubation |period |7-17 |days |(asymptomatic |and |not |contagious)
-first |s/s; |fever, |malaise, |aches |(2-4 |days), |sometimes |contagious |
-early |rash; |small |red |spots |on |tongue |and |mouth |
- |break |open |and |virus |spreads
-MOST |contagious |time
- |rash |spreads |to |body |on |extremities
-pustular |rash |through |scab |and |recovery
-contagious |until |scabs |have |fallen |off
-contact |FBI |is |considered |a |bioterrorist |attack
- |lesions |differ |from |chicken |pox
-small |pox |lesions |develop |at |same |rate |as |chicken |pox |,then |become |pus |filled, |then |start |to |scab
- |mainly |on |face |and |extremities
smallpox |facts |- |correct |answer | |-last |case |1949 |in |US |and |1977 |in |somalia
-routine |vaccination |stopped |after |last |case
- |vaccine |only |prevention
, - |can |work |within |3 |days |of |exposure
- |transmitted |direct |and |prolonged |face |to |face |contact
-contact |with |infected |body |fluids
- |contact |with |contaminated |objects
response |is |smallpox |outbreak |- |correct |answer | |-mass |vaccinations
-crowd |control, |record |keeping |and |prioritization
category |A |- |correct |answer | |-high |priority |agents |including |organisms |that |pose |a |risk |to |national |
security |because |they |are |easily |transmitted
-high |mortality |rates |and |have |potential |for |major |public |health |impact
-might |cause |public |panic |and |social |disruption
- |require |special |action |for |public |health |preparedness
- |Anthrax |• |Botulism |• |Plague |• |Smallpox |• |Tularemia |• |Viral |hemorrhagic |fevers |(filoviruses |[e.g., |
Ebola, |Marburg] |and |arenaviruses |[e.g., |Lassa, |Machupo])
category |B |- |correct |answer | |-second |highest |priority |agents |include |those |that |are |moderately |easy |
to |disseminate
-result |in |moderate |morbidity |rates |and |low |mortality |rates
-require |specific |enhancement |of |CDCs |diagnostic |capacity |and |enhanced |disease |surveillance |
-brucellosis, |clostridium |perfringens, |salmonella, |e. |coli, |shigella, |q |fever, |ricin*, |staph |b, |vibrio |
cholerae, |cryptosporidium
category |C |- |correct |answer | |third |highest |priority |agents |include |emerging |pathogens |that |could |be |
engineered |for |mass |dissemination |in |the |future |because |of |: |availability |and |ease |of |production |and |
dissemination |and |potential |for |high |morbidity |and |mortality |rates |and |major |health |impact |
- |nipah |virus, |hantavirus, |HIV, |SARS, |H1N1
strategic |national |stockpile |- |correct |answer | |The |United |States' |national |repository |of |antibiotics, |
vaccines, |chemical |antidotes, |antitoxins, |and |other |critical |medical |equipment |and |supplies
